2009 No. 2230
National Health Service, England

The National Health Service (Prescribing and Charging Amendments Relating to Pandemic Influenza) Regulations 2009

Made
Laid before Parliament
Coming into force
The Secretary of State makes the following Regulations in exercise of the powers conferred by sections 88, 89, 94, 172, 182, 184(1), 272(7) and (8) and 275(1) of the National Health Service Act 20061.

Citation, commencement and application1.

(1)

These Regulations may be cited as the National Health Service (Prescribing and Charging Amendments Relating to Pandemic Influenza) Regulations 2009 and come into force on 21st August 2009.

(2)

These Regulations apply in relation to England.

Amendment of the National Health Service (Charges for Drugs and Appliances) Regulations 20002.

In the National Health Service (Charges for Drugs and Appliances) Regulations 20002, after regulation 7B3, insert the following regulation—

“Exemption from charges in respect of listed medicines7C.

(1)

No patient shall be liable to pay a charge under these Regulations in respect of the following medicines—

(a)

oseltamivir (marketed as Tamiflu);

(b)

zanamivir (marketed as Relenza),

in the circumstances set out in paragraph (2).

(2)

Those circumstances are that—

(a)

the Secretary of State has made arrangements for supplying the medicine to patients free of charge; or

(b)

the NHS body that is responsible for the arrangements under which the medicine is supplied has made arrangements, with the approval of the Secretary of State, for supplying the medicine to patients free of charge,

and the patient is supplied with the medicine under those arrangements.”.

Amendment of the National Health Service (General Medical Services Contracts) Regulations 20043.

In the National Health Service (General Medical Services Contracts) Regulations 20044—

(a)

in regulation 25 (interpretation), in paragraph (1), after the definition of “limited partnership” insert the following definitions—

““listed medicine” means a medicine mentioned in regulation 7C(1) of the National Health Service (Charges for Drugs and Appliances) Regulations 2000;

“listed medicines voucher” means a form provided by a Primary Care Trust for use for the purpose of ordering a listed medicine;”;

(b)

in paragraph 386 of Schedule 6 (other contractual terms – prescribing)—

(i)

in sub-paragraph (a), omit “and”,

(ii)

in sub-paragraph (b), for “professional,” substitute “professional, and”, and

(iii)

after sub-paragraph (b), insert the following sub-paragraph—

“(c)

any listed medicines voucher issued by a prescriber or any other person acting under the contract,”;

(c)

in paragraph 397 of Schedule 6 (other contractual terms – prescribing)—

(i)

in sub-paragraph (1), after “sub-paragraph (1A)” insert “and (1B)”, and

(ii)

after sub-paragraph (1A), insert the following sub-paragraphs—

“(1B)

During an outbreak of an illness for which a listed medicine may be used for treatment or for prophylaxis, if—

(a)

the Secretary of State or the Primary Care Trust has made arrangements for the distribution of a listed medicine in the area of the Primary Care Trust free of charge; and

(b)

that listed medicine is needed for treatment or prophylaxis of any patient who is receiving treatment under the contract,

a prescriber may, or if the patient has not attained the age of 13 years must, order that listed medicine by using a listed medicines voucher, which the prescriber must sign.

(1C)

During an outbreak of an illness for which a listed medicine may be used for treatment or for prophylaxis, if—

(a)

the Secretary of State or the Primary Care Trust has made arrangements for the distribution of a listed medicine in the area of the Primary Care Trust free of charge;

(b)

those arrangements contain criteria set out in a protocol which enable persons who are not prescribers to identify the symptoms of, and whether there is a need for treatment or prophylaxis of, that disease;

(c)

a person acting on behalf of the contractor, who is not a prescriber but who is authorised to order listed medicines by the Primary Care Trust, has applied the criteria referred to in paragraph (b) to any patient who is receiving treatment under the contract; and

(d)

having applied the criteria, the person acting on behalf of the contractor has concluded that the listed medicine is needed for treatment or prophylaxis of that patient,

the person acting on behalf of the contractor must order that listed medicine by using a listed medicines voucher, which the person ordering the listed medicine must sign.”;

(d)

in paragraph 428 of Schedule 6 (other contractual terms – restrictions on prescribing by medical practitioners)—

(i)

in sub-paragraph (1), after “shall not order on” insert “a listed medicines voucher,”, and

(ii)

in sub-paragraph (2)—

(aa)

after “shall not order on” insert “a listed medicines voucher,”,

(bb)

for paragraph (c) substitute the following paragraph—

“(c)

if the order is on a prescription form, the practitioner includes—

(i)

the reference “SLS”, or

(ii)

if the order is under arrangements made by the Secretary of State or the Primary Care Trust for the distribution of a listed medicine free of charge, the reference “ACP”,”; and

(e)

in paragraph 439 of Schedule 6 (other contractual terms – restrictions on prescribing by supplementary prescribers), in sub-paragraph (2)(d)(iii), for “prescription, he includes on the prescription form the reference “SLS”” substitute “prescription on a prescription form, the prescriber includes on the form the reference “SLS” or, in the case of a listed medicine ordered under arrangements made by the Secretary of State or the Primary Care Trust for the medicine’s distribution free of charge, the reference “ACP””.

Amendment of the National Health Service (Personal Medical Services Agreements) Regulations 20044.

In the National Health Service (Personal Medical Services Agreements) Regulations 200410—

(a)

in regulation 211 (interpretation), in paragraph (1), after the definition of “licensing body” insert the following definitions—

““listed medicine” means a medicine mentioned in regulation 7C(1) of the National Health Service (Charges for Drugs and Appliances) Regulations 2000;

“listed medicines voucher” means a form provided by a Primary Care Trust for use for the purpose of ordering a listed medicine;”;

(b)

in paragraph 3712 of Schedule 5 (other contractual terms – prescribing), in sub-paragraph (1)—

(i)

at the end of paragraph (a), omit “and”,

(ii)

in paragraph (b), for “professional,” substitute “professional; and”, and

(iii)

after paragraph (b), insert the following paragraph—

“(c)

any listed medicines voucher issued by a prescriber or any other person acting under the contract,”;

(c)

in paragraph 3813 of Schedule 5 (other contractual terms – prescribing)—

(i)

in sub-paragraph (1), after “sub-paragraph (1A)” insert “and (1B)”, and

(ii)

after sub-paragraph (1A), insert the following sub-paragraphs—

“(1B)

During an outbreak of an illness for which a listed medicine may be used for treatment or for prophylaxis, if—

(a)

the Secretary of State or the Primary Care Trust has made arrangements for the distribution of a listed medicine in the area of the Primary Care Trust free of charge; and

(b)

that listed medicine is needed for treatment or prophylaxis of any patient who is receiving treatment under the contract,

a prescriber may, or if the patient has not attained the age of 13 years must, order that listed medicine by using a listed medicines voucher, which the prescriber must sign.

(1C)

During an outbreak of an illness for which a listed medicine may be used for treatment or for prophylaxis, if—

(a)

the Secretary of State or the Primary Care Trust has made arrangements for the distribution of a listed medicine in the area of the Primary Care Trust free of charge;

(b)

those arrangements contain criteria set out in a protocol which enable persons who are not prescribers to identify the symptoms of, and whether there is a need for treatment or prophylaxis of, that disease;

(c)

a person acting on behalf of the contractor, who is not a prescriber but who is authorised to order listed medicines by the Primary Care Trust, has applied the criteria referred to in paragraph (b) to any patient who is receiving treatment under the contract; and

(d)

having applied the criteria, the person acting on behalf of the contractor has concluded that the listed medicine is needed for treatment or prophylaxis of that patient,

the person acting on behalf of the contractor must order that listed medicine by using a listed medicines voucher, which the person ordering the listed medicine must sign.”;

(d)

in paragraph 4114 of Schedule 5 (other contractual terms – restrictions on prescribing by medical practitioners)—

(i)

in sub-paragraph (1), after “shall not order on” insert “a listed medicines voucher,”, and

(ii)

in sub-paragraph (2)—

(aa)

after “shall not order on” insert “a listed medicines voucher,”, and

(bb)

for paragraph (c) substitute the following paragraph—

“(c)

if the order is on a prescription form, the practitioner includes—

(i)

the reference “SLS”, or

(ii)

if the order is under arrangements made by the Secretary of State or the Primary Care Trust for the distribution of a listed medicine free of charge, the reference “ACP”,”; and

(e)

in paragraph 4215 of Schedule 5 (other contractual terms – restrictions on prescribing by supplementary prescribers), in sub-paragraph (2)(d)(iii), for “prescription, he includes on the prescription form the reference “SLS”” substitute “prescription on a prescription form, the prescriber includes on the form the reference “SLS” or, in the case of a listed medicine ordered under arrangements made by the Secretary of State or the Primary Care Trust for the medicine’s distribution free of charge, the reference “ACP””.

Amendment of the National Health Service (General Medical Services Contracts) (Prescription of Drugs etc.) Regulations 20045.

In Schedule 2 to the National Health Service (General Medical Services Contracts) (Prescription of Drugs etc.) Regulations 200416 (drugs, medicines and other substances that may only be ordered in certain circumstances)—

(a)

in the entry for “Oseltamivir (Tamiflu)”—

(i)

in the part which relates to “treatment of influenza” (as mentioned in column 3), in column 2, after paragraph (1) insert—

“(1A)

Any patient suffering from influenza during an outbreak of pandemic influenza (influenza caused by a new virus subtype that has an increased and sustained transmission during a global outbreak of influenza), where the drug is ordered under arrangements for the distribution of the drug free of charge which are approved by the Secretary of State or are part of a Primary Care Trust’s antivirals distribution service17.”, and

(ii)

in the part which relates to “prophylaxis of influenza” (as mentioned in column 3), in column 2, after paragraph (2) insert—

“(2A)

Any patient at risk from influenza during an outbreak of pandemic influenza (influenza caused by a new virus subtype that has an increased and sustained transmission during a global outbreak of influenza), where the drug is ordered under arrangements for the distribution of the drug free of charge which are approved by the Secretary of State or are part of a Primary Care Trust’s antivirals distribution service.”; and

(b)

in the entry for “Zanamivir (Relenza)”—

(i)

number the current paragraph for the entry in column 2 as “(1)”, and then after that paragraph add the following paragraph—

“(2)

Any patient at risk of or suffering from influenza during an outbreak of pandemic influenza (influenza caused by a new virus subtype that has an increased and sustained transmission during a global outbreak of influenza), where the drug is ordered under arrangements for the distribution of the drug free of charge which are approved by the Secretary of State or are part of a Primary Care Trust’s antivirals distribution service.”, and

(ii)

in column 3, opposite paragraph (2) in column 2, insert—

“Prophylaxis or treatment of influenza.”.

Signed by authority of the Secretary of State for Health.

Gillian Merron
Minister of State,
Department of Health
EXPLANATORY NOTE
(This note is not part of the Regulations)

These Regulations further amend the National Health Service (Charges for Drugs and Appliances) Regulations 2000 (“the Charges Regulations”), the National Health Service (General Medical Services Contracts) Regulations 2004 (“the GMS Regulations”), the National Health Service (Personal Medical Services Agreements) Regulations 2004 (“the PMS Regulations”) and the National Health Service (General Medical Services Contracts) (Prescription of Drugs etc.) Regulations 2004 (“the Drugs Regulations”).

Regulation 2 inserts a new exemption into the Charges Regulations, the new regulation 7C, the effect of which is that two named antiviral medicines will be exempt from the charging arrangements in the Charges Regulations, if distributed under arrangements for their free supply made by the Secretary of State or a relevant National Health Service body (with the approval of the Secretary of State).

Regulations 3 and 4 amend the GMS Regulations and the PMS Regulations so that during outbreaks of pandemic influenza, orders for the same two antiviral medicines for patients aged 13 and over can be written either on a new voucher or on the standard prescription form (in the latter case, with the endorsement “ACP”), where these medicines are being ordered by qualified prescribers under arrangements made by the Secretary of State or a Primary Care Trust for the distribution of these medicines free of charge. However, a qualified prescriber must use the new voucher for an order under those arrangements, if the order is for a patient aged 12 or under.

Amendments are also made to provide for the ordering of these medicines by authorised people who are not qualified prescribers, if they are following criteria which enable them to do so and which are set under the arrangements for free distribution. However, any people ordering these medicines who are not qualified prescribers must use the new voucher rather than the standard prescription form.

Regulation 5 amends the entries for the same two antiviral medicines in Schedule 2 to the Drugs Regulations, with the effect of widening the circumstances under which they may be ordered for patients under general medical services contracts and personal medical services agreements. Essentially, they may be ordered during outbreaks of pandemic influenza for treatment or prophylaxis of influenza, where this is under arrangements for the distribution of the medicines free of charge which are approved by the Secretary of State or are part of a Primary Care Trust’s antivirals distribution service.